Press Releases
Search
-
09 Oct 2015
BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform...
-
24 Sep 2015
BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization
Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and Listing...
-
31 Aug 2015
bioMérieux – First-Half 2015 Results
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Sharp 34% improvement in contributive operating income before non-recurring items lifted by strong business m...
-
27 Jul 2015
bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®
Marcy l'Etoile, France, July 27, 2015 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This inst...
-
17 Jul 2015
First-Half 2015 Business Review
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up...
-
22 Jun 2015
Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux
For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat.